|
RRN3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.60849999999835E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.712300E-02 |
| Normal-vs-Stage2 |
4.696500E-02 |
| Normal-vs-Stage3 |
1.555750E-04 |
| Normal-vs-Stage4 |
8.032400E-02 |
| Stage1-vs-Stage2 |
2.549200E-01 |
| Stage1-vs-Stage3 |
2.702000E-03 |
| Stage1-vs-Stage4 |
2.468800E-01 |
| Stage2-vs-Stage3 |
1.894410E-01 |
| Stage2-vs-Stage4 |
9.854400E-01 |
| Stage3-vs-Stage4 |
2.768800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.8765300000001E-05 |
| Normal-vs-AfricanAmerican |
2.485200E-01 |
| Normal-vs-Asian |
1.695790E-01 |
| Caucasian-vs-AfricanAmerican |
1.640340E-02 |
| Caucasian-vs-Asian |
2.779000E-01 |
| AfricanAmerican-vs-Asian |
2.426600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.629670E-04 |
| Normal-vs-Female |
1.441380E-03 |
| Male-vs-Female |
4.874200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.758300E-02 |
| Normal-vs-Extreme_Weight |
9.680600E-03 |
| Normal-vs-Obese |
2.275100E-03 |
| Normal-vs-Extreme_Obese |
1.925770E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.878800E-01 |
| Normal_Weight-vs-Obese |
7.388400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.551000E-01 |
| Extreme_Weight-vs-Obese |
3.046800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.958000E-01 |
| Obese-vs-Extreme_Obese |
8.637600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.548300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.209750E-04 |
| Normal-vs-Age(61-80Yrs) |
3.741800E-03 |
| Normal-vs-Age(81-100Yrs) |
1.538380E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.546600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.117200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.763000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.447000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.543600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.332400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.579150E-03 |
| Normal-VS-Type2 PRCC |
5.70020000000282E-05 |
| Normal-VS-KIRP CIMP |
1.311980E-02 |
| Normal-VS-Unclassified PRCC |
3.909600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.617800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.479410E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.921200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.250600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.196400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.831400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.212100E-02 |
| Normal-vs-N1 |
2.964600E-04 |
| Normal-vs-N2 |
2.908000E-01 |
| N0-vs-N1 |
5.242200E-02 |
| N0-vs-N2 |
8.652600E-01 |
| N1-vs-N2 |
2.727200E-01 |
|
|
